Headline: NeoGenomics to Acquire Inivata - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform
Location: US
Post Date: May 5, 2021 12:04 AM
TAG ID: awire074374
DocID: 644660
Word Count: approx. 1794 words
 
NeoGenomics to Acquire Inivata - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform <p><b><i>Establishes NeoGenomics as a technology leader in the minimal residual disease (MRD) testing market </i></b
 
Please login to download this Story